Point72 Asia (Singapore) Pte. Ltd. Maravai Lifesciences Holdings, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding MRVI
# of Institutions
235Shares Held
141MCall Options Held
223KPut Options Held
19.4K-
Gtcr LLC20.2MShares$113 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$78.7 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$66.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$54.7 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$46.9 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $739M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...